NCT05826535 2026-02-24Study of LYL314 in Aggressive Large B-Cell LymphomaLyell Immunopharma, Inc.Phase 1/2 Recruiting270 enrolled
NCT05963217 2025-07-02Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLUniversity Health Network, TorontoPhase 1 Recruiting19 enrolled